Worldwide practice in gastric cancer surgery

被引:59
作者
Brenkman, Hylke J. F. [1 ]
Haverkamp, Leonie [1 ]
Ruurda, Jelle P. [1 ]
van Hillegersberg, Richard [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands
关键词
Gastric cancer; Gastrectomy; Laparoscopy; Neoplasm; Minimally invasive surgery; LYMPH-NODE DISSECTION; LAPAROSCOPIC TOTAL GASTRECTOMY; OPEN DISTAL GASTRECTOMY; IN-HOSPITAL MORTALITY; QUALITY-OF-LIFE; D2; LYMPHADENECTOMY; CHEMOTHERAPY; TRIAL; ESOPHAGEAL; CHEMORADIOTHERAPY;
D O I
10.3748/wjg.v22.i15.4041
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the current status of gastric cancer surgery worldwide. METHODS: An international cross-sectional survey on gastric cancer surgery was performed amongst international upper gastro-intestinal surgeons. All surgical members of the International Gastric Cancer Association were invited by e-mail to participate. An English web-based survey had to be filled in with regard to their surgical preferences. Questions asked included hospital volume, the use of neoadjuvant treatment, preferred surgical approach, extent of the lymphadenectomy and preferred anastomotic technique. The invitations were sent in September 2013 and the survey was closed in January 2014. RESULTS: The corresponding specific response rate was 227/615 (37%). The majority of respondents: originated from Asia (54%), performed > 21 gastrectomies per year (79%) and used neoadjuvant chemotherapy (73%). An open surgical procedure was performed by the majority of surgeons for distal gastrectomy for advanced cancer (91%) and total gastrectomy for both early and advanced cancer (52% and 94%). A minimally invasive procedure was preferred for distal gastrectomy for early cancer (65%). In Asia surgeons preferred a minimally invasive procedure for total gastrectomy for early cancer also (63%). A D1+ lymphadenectomy was preferred in early gastric cancer (52% for distal, 54% for total gastrectomy) and a D2 lymphadenectomy was preferred in advanced gastric cancer (93% for distal, 92% for total gastrectomy) CONCLUSION: Surgical preferences for gastric cancer surgery vary between surgeons worldwide. Although the majority of surgeons use neoadjuvant chemotherapy, minimally invasive techniques are still not widely adapted.
引用
收藏
页码:4041 / 4048
页数:8
相关论文
共 44 条
[1]   Outcomes of Non-Operative Treatment for Duodenal Stump Leakage after Gastrectomy in Patients with Gastric Cancer [J].
Ali, Bandar Idrees ;
Park, Cho Hyun ;
Song, Kyo Young .
JOURNAL OF GASTRIC CANCER, 2016, 16 (01) :28-33
[2]   Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers [J].
Bachmann, MO ;
Alderson, D ;
Edwards, D ;
Wotton, S ;
Bedford, C ;
Peters, TJ ;
Harvey, IM .
BRITISH JOURNAL OF SURGERY, 2002, 89 (07) :914-922
[3]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[4]   Hospital volume and surgical mortality in the United States. [J].
Birkmeyer, JD ;
Siewers, AE ;
Finlayson, EVA ;
Stukel, TA ;
Lucas, FL ;
Batista, I ;
Welch, HG ;
Wennberg, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137
[5]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[6]   LYMPH-NODE DISSECTION IN GASTRIC-CANCER [J].
BONENKAMP, JJ ;
VANDEVELDE, CJH .
BRITISH JOURNAL OF SURGERY, 1995, 82 (07) :867-869
[7]   Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients [J].
Callahan, MA ;
Christos, PJ ;
Gold, HT ;
Mushlin, AI ;
Daly, JM .
ANNALS OF SURGERY, 2003, 238 (04) :629-636
[8]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[9]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[10]   Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer [J].
Degiuli, M. ;
Sasako, M. ;
Ponti, A. ;
Vendrame, A. ;
Tomatis, M. ;
Mazza, C. ;
Borasi, A. ;
Capussotti, L. ;
Fronda, G. ;
Morino, M. .
BRITISH JOURNAL OF SURGERY, 2014, 101 (02) :23-31